Mesirow Financial Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Mesirow Financial Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-54,427	Closed	-$349K	–	62
2019 Q2	$349K	Buy	54,427 +5,854	+12%	+$41.2K	1.27%	48
2019 Q1	$344K	Buy	48,573 +15,572	+47%	+$103K	1.37%	41
2018 Q4	$160K	Hold	33,001	–	–	1.03%	52
2018 Q3	$243K	Sell	33,001 -2,580	-7%	-$18.9K	1.25%	49
2018 Q2	$227K	Sell	35,581 -6,577	-16%	-$43.5K	1.01%	53
2018 Q1	$229K	Buy	+42,158	New	+$210K	0.96%	53
2017 Q4	–	Sell	-28,800	Closed	-$277K	–	62
2017 Q3	$277K	Buy	+28,800	New	+$299K	1.31%	48

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mesirow Financial Investment Management's GNMK Position: Q3 2019 in Review

Mesirow Financial Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2019, closing a stake of 54,427 shares — an estimated $349K sold.

Mesirow Financial Investment Management first reported a position in GNMK in Q3 2017 and held it in 7 quarters. The position peaked at $349K in Q2 2019. 110 funds tracked by Wall St. Rank hold GNMK as of Q3 2019.

Mesirow Financial Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q3 2019 after selling out during the quarter.
Mesirow Financial Investment Management sold 54,427 GenMark Diagnostics, Inc shares in Q3 2019, an estimated $349K.
Mesirow Financial Investment Management first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 7 quarters.
Mesirow Financial Investment Management's GenMark Diagnostics, Inc position peaked at $349K in Q2 2019.
110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2019.

Based on Mesirow Financial Investment Management's 13F filing for Q3 2019, filed 30 Oct 2019.